Chester County News and Community Website
Are you looking for Chester County businesses that are traded on the Nasdaq Stock Market? Would you love adding a Chester County business to your investment portfolio or 401k? The process of building a properly diversified portfolio, which includes investments in local businesses, is an important personal financial strategy.
Here you will find news and updates from Chester County businesses that are listed on the Nasdaq Stock Market. There is a growing appetite for real, local business news about publicly traded companies. MyChesCo features local business news from around Chester County. Moreover, we provide in-depth articles about Chester County’s dynamic business and economic scene, including tips for small biz owners, marketing, management, startups, entrepreneurship, and more.
WAYNE, PA — BTCS Inc. (Nasdaq: BTCS) Chief Executive Officer Charles Allen will discuss the company’s Ethereum-focused strategy with investors Sept. 15 at the H.C. Wainwright Annual Global Investment Conference …
BTCS Puts Ethereum Strategy Before Investors at Conference Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) will present its dermatology drug portfolio to investors Monday at the H.C. Wainwright 28th Annual Global Investment Conference in New York …
Verrica Puts Investor Focus on Dermatology Pipeline Read More
PHILADELPHIA, PA — Bentley Systems Inc. (Nasdaq: BSY) has consolidated about 150 engineering, technology and business employees in a new 22,000-square-foot Philadelphia office, bringing its longtime Cherry Street operation and …
Bentley Consolidates Philadelphia Teams in New Tech Hub Read More
WAYNE, PA — Aclaris Therapeutics Inc. (Nasdaq: ACRS) Chief Executive Officer Neal Walker will address investors Sept. 10 at the Cantor Global Healthcare Conference in New York as the clinical-stage …
Aclaris CEO to Detail Drug Pipeline at Cantor Conference Read More
WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) Chief Executive Officer Wes Kaupinen will appear at two healthcare investor conferences in September, giving investors two near-term opportunities to hear from …
Palvella CEO to Pitch Rare-Disease Pipeline at Investor Meets Read More
MALVERN, PA — Ocugen Inc. (Nasdaq: OCGN) has dosed the first patient in a global Phase 3 trial of OCU410, moving its one-time gene therapy for geographic atrophy into pivotal …
Malvern’s Ocugen Starts Pivotal Trial for Eye Gene Therapy Read More WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) recently completed its U.S. application for approval of QTORIN™ rapamycin to treat microcystic lymphatic malformations, putting the Wayne-based biotechnology company on a …
ICYMI: Palvella Seeks FDA Approval for Rare-Disease Skin Therapy Read More
MALVERN, PA — TELA Bio Inc. (Nasdaq: TELA) plans to eliminate 41 jobs and reduce outside expenses under a restructuring expected to lower annual operating costs by $17 million as …
TELA Bio Cuts 41 Jobs as Losses Pressure Cash Position Read More WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) has completed its application for U.S. approval of QTORIN 3.9% rapamycin anhydrous gel to treat microcystic lymphatic malformations, moving the Wayne-based biotechnology …
Palvella Files FDA Bid for QTORIN Rapamycin in Rare Disease Read More MALVERN, PA — TELA Bio (Nasdaq: TELA) is cutting annual operating expenses by about $17 million and reducing its workforce by roughly 20%, a restructuring the medical technology company expects …
Malvern MedTech Cuts 20% of Staff as CFO Exits Read More